Cyanotech Works To Expand Astaxanthin Applications, Acceptance

Cyanotech Works To Expand Astaxanthin Applications, Acceptance

KAILUA-KONA, Hawaii--Cyanotech Corp. (NASDAQ:CYAN)reported that for its second quarter (2Q03), ended Sept. 30 and announced Oct.29, sales may be down but hopes for integrating its astaxanthin into differentapplications were up.

Sales increased for the quarter, coming in at $2.0 million from2Q02's $1.95 million; however, the company's net loss was larger, logging in at$540,000, or $.03 per share lost, compared to 2Q02's loss of $509,000, or $.03per share lost.

The company is currently working with various aspects of thenutraceutical industry--cosmetics, direct marketing and natural foodcompanies--in order to better integrate the company's astaxanthin products.

In terms of getting out the company's product information, itlaunched an infomercial for BioAstin and its effects on joint pain relief;results of how consumers are reacting to this marketing message were to bereported in late November.